TY  - JOUR
AU  - Mazzanti, Andrea
AU  - Kukavica, Deni
AU  - Trancuccio, Alessandro
AU  - Memmi, Mirella
AU  - Bloise, Raffaella
AU  - Gambelli, Patrick
AU  - Marino, Maira
AU  - Ortíz-Genga, Martín
AU  - Morini, Massimo
AU  - Monteforte, Nicola
AU  - Giordano, Umberto
AU  - Keegan, Roberto
AU  - Tomasi, Luca
AU  - Anastasakis, Aristides
AU  - Davis, Andrew M
AU  - Shimizu, Wataru
AU  - Blom, Nico A
AU  - Santiago, Demetrio Julián
AU  - Napolitano, Carlo
AU  - Monserrat, Lorenzo
AU  - Priori, Silvia G.
PY  - 2022
DO  - 10.1001/jamacardio.2022.0219
UR  - http://hdl.handle.net/20.500.12105/15637
AB  - Patients with catecholaminergic polymorphic ventricular tachycardia (CPVT) may experience life-threatening arrhythmic events (LTAEs) despite β-blocker treatment. Further complicating management, the role of implantable cardioverter defibrillator (ICD)...
LA  - eng
PB  - American Medical Association
KW  - Nadolol
KW  - Tachycardia, Ventricular
KW  - Adolescent
KW  - Adrenergic beta-Antagonists
KW  - Adult
KW  - Child
KW  - Cohort Studies
KW  - Electrocardiography
KW  - Female
KW  - Humans
KW  - Male
KW  - Prospective Studies
KW  - Ryanodine Receptor Calcium Release Channel
KW  - Syncope
KW  - Young Adult
TI  - Outcomes of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia Treated With β-Blockers.
TY  - journal article
ER  -